How Many Batches Are Needed for Process Validation under the New FDA Guidance?

References

1. 1.↵
   U.S. FDA Guidance for Industry on Process Validation: General Principles and Practices, 2011.

   Google Scholar
2. 2.↵
   ICH Q8(R2). Pharmaceutical Development, 2006.

   Google Scholar
3. 3.↵
   ICH Q9. Quality Risk Management, 2007.

   Google Scholar
4. 4.↵
   ICH Q10. Pharmaceutical Quality Systems, 2007.

   Google Scholar
5. 5.↵
   ICH Q11. Concept Paper, 2011.

   Google Scholar
6. 6.↵
   FDA Guideline on General Principles of Process Validation. FDA: Rockville, MD, May, 1987.

   Google Scholar
7. 7.↵
   1. Berger J. O

   . Statistical Decision Theory and Bayesian Analysis, 2nd ed.; Springer: New York, 2010.

   Google Scholar
8. 8.↵
   1. Bayes T. R

   . An essay towards solving a problem in the doctrine of chances. Philos Trans. Roy. Soc. London 1763, 53, 370–418. Reprinted with an introduction by Barnard, G. Biometrika 1958, 45, 293–315.

   OpenUrlCrossRefGoogle Scholar
9. 9.↵
   1. Spiegelhalter D. J.,
   2. Abrams K. R.,
   3. Myles J. P

   . Bayesian Approaches to Clinical Trials and Health-Care Evaluation; Wiley: Hoboken, NJ, 2004.

   Google Scholar
10. 10.↵
    1. Hahn G. J.,
    2. Nelson W. A

    . survey of prediction intervals and their applications. J. Qual. Technol. 1973, 5 (4), 178– 188.

    OpenUrlGoogle Scholar
11. 11.↵
    1. Agresti A

    . On logit confidence intervals for the odds ratio with small samples. Biometrics 1999, 55 (2), 597– 602.

    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar